Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|September 28, 2010
Biological role and prognostic significance of NAC1 in ovarian cancerKentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, et al.
Experimental and Therapeutic Medicine|September 21, 2012
MEK inhibition suppresses cell invasion and migration in ovarian cancers with activation of ERK1/2Atsuko Katagiri, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Human Pathology|September 4, 2012
Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancerMunmun Rahman, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2012
[A case of stage IVb cervical carcinoma in which survival was prolonged by two different chemotherapies and CCRT]Masako Ishikawa, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Oncotarget|July 10, 2018
Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progressionNaomi Nakayama, Gyosuke Sakashita, Yuko Nariai, et al.
Oncology|January 12, 2013
Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancerMohammed Tanjimur Rahman, Kentaro Nakayama, Masako Ishikawa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 14, 2011
MKK4 acts as a potential tumor suppressor in ovarian cancerShamima Yeasmin, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Anticancer Research|June 25, 2003
Serum endostatin levels in patients with epithelial ovarian cancerKohkichi Hata, Dipok Kumar Dhar, Haruhiko Kanasaki, et al.
International Journal of Cancer|March 24, 2010
Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transitionShamima Yeasmin, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Pageof 18